How are you feeling today? Keep up to date on news and stories related to health care here!
Expanded Access Program Established for Patients in the U.S. Who May Benefit from Investigational Therapy While Application is Under Review RARITAN, N.J.–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a Biologics License Application (BLA) to the
FILE – In this March 16, 2020, file photo, Neal Browning receives a shot in the first-stage safety study of a potential vaccine for COVID-19 at the Kaiser Permanente Washington Health Research Institute in Seattle. Moderna Inc., said Monday, Nov. 16, its
Why do we need acts of charity to rescue Americans from crushing medical bills? — NYT: Top Stories
The northern Italian province became one of the deadliest killing fields for the virus in the Western world. But a Times investigation found that faulty guidance and bureaucratic delays rendered the toll far worse than it had to be. — NYT: Top
It began as a stopgap way to get through the pandemic, but both participants and providers say virtual sessions have some clear advantages and will likely become a permanent part of recovery. — NYT: Top Stories
ENGLEWOOD CLIFFS, N.J.–(BUSINESS WIRE)–Unilever announced today that it has signed an agreement to acquire SmartyPants Vitamins, a U.S.-based Vitamin, Mineral & Supplement company. Based in Los Angeles, SmartyPants Vitamins was founded in 2011 by entrepreneurs Courtney Nichols Gould and Gordon Gould, who
First immunotherapy to be approved for a gastroesophageal cancer in the European Union Approval based on Phase 3 ATTRACTION-3 trial showing statistically significant and clinically meaningful improvement in overall survival compared to chemotherapy PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #BMS—Bristol Myers Squibb (NYSE: BMY) today
SOMERSET, N.J.–(BUSINESS WIRE)–Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, announced today that it has appointed Dr. Li Zhu to Legend Biotech’s Board
The project will aim to ship vaccines as soon as they receive approval, meaning that they hope to start seeing immunization starting December 11th or 12th. — FOX News